Since 2021 and the end of reimbursement for homeopathy in France, which led to 500 job cuts and the sale of the Montrichard (Loir-et-Cher) factory to Prova, Boiron has tried to diversify into cosmetics and CBD-based care and treatments. Without managing to redress the situation.
100 million euros less revenue
Thierry Boiron, general manager of the family business, refuses to speak, especially since negotiations with the staff representation institutions (IRP) will start at the beginning of December, a spokesperson for the company told L’Usine Nouvelle. direction.
In detail, this project should lead to the elimination of 117 filled positions and 28 vacant ones. If the factories are spared, four preparation and distribution establishments in Clermont-Ferrand (Puy-de-Dôme), Dijon (Côte-d’Or), Reims (Marne) and Sophia-Antipolis (Alpes-Maritimes), will be closed , leading to the elimination of 73 positions. According to our information, the preparation of tailor-made treatments will be concentrated on the last four establishments in Sainte-Foy-lès-Lyon (Rhône), Lille (Nord), Pantin (Seine-Saint-Denis) and Montpellier (Hérault).
In addition, the elimination of 40 positions is planned within the distribution establishments of Bordeaux (Gironde), Marseille (Bouches-du-Rhône), Nancy (Meurthe-et-Moselle), Nantes (Loire-Atlantique), Rennes (Ille -et-Vilaine), Toulouse (Haute-Garonne), Tours (Indre-et-Loire), as well as 32 positions in the medical examination.
«This plan is not a surprise, we expected announcements. We consider it very damaging to undermine our tailor-made preparation capacity», Reacts Alain Cohard, central union representative (CFE-CGC), who is also concerned about the positions of medical visitors being eliminated, even though they are in contact with prescribing doctors.
The homeopathy market has suffered since the dereimbursement by Social Security. “Volumes have been divided by three in five years, signifying a drop of more than 100 million euros in turnover», Indicates the group.
This family business, listed on the stock exchange, will offer “a set of support measures aimed in particular at favoring voluntary departures and age measures”, in other words aid for employees close to retirement.
Homeopathy, previously reimbursed at 65%, saw its reimbursement rate gradually decrease before being completely abandoned due to the lack of evidence of effectiveness. More than 500 positions had already been eliminated in 2021. Last summer, general director Valérie Lorentz-Poinsot was ousted. The Boiron family then took control by appointing Thierry Boiron, who is responsible for leading this new social plan.
Source: www.usinenouvelle.com
